The Centre informed the Supreme Court that India had a very low incidence of Adverse Events Following Immunisation (AEFI) cases of Thrombosis and Thrombocytopenia Syndrome (TTS) during administration of 220 crore doses of Covid-19 vaccines. It said till September 30 this year India has administered 219.9 crore doses of Covid-19 vaccine. A total 26 AEFI cases of TTS were reported, of which 14 recovered and 12 died.The Centre informed the Supreme Court that India had a very low incidence of Adverse Events Following Immunisation (AEFI) cases of Thrombosis and Thrombocytopenia Syndrome (TTS) during administration of 220 crore doses of Covid-19 vaccines. It said till September 30 this year India has administered 219.9 crore doses of Covid-19 vaccine. A total 26 AEFI cases of TTS were reported, of which 14 recovered and 12 died.